AAAAAA

   
Results: 1-8 |
Results: 8
ANALYSIS OF HEPATITIS-C INFECTED HEPATOCYTES BY INTRACELLULAR STAINING AND FLOW-CYTOMETRY
Authors: CARONIA S GULATI V RAJANANTHANAN P MCGARVEY M GOLDIN RD THOMAS HC FOSTER GR
Citation: S. Caronia et al., ANALYSIS OF HEPATITIS-C INFECTED HEPATOCYTES BY INTRACELLULAR STAINING AND FLOW-CYTOMETRY, Hepatology, 28(4), 1998, pp. 1609-1609
PHYSICAL CHARACTERIZATION OF ORGANIC PIGMENT POWDERS
Authors: MCGARVEY M MCKAY RB
Citation: M. Mcgarvey et Rb. Mckay, PHYSICAL CHARACTERIZATION OF ORGANIC PIGMENT POWDERS, Surface coatings international, 80(9), 1997, pp. 435
PARTICLE-SIZE ANALYSIS BY LASER DIFFRACTION IN ORGANIC PIGMENT TECHNOLOGY
Authors: MCGARVEY M MCGREGOR D MCKAY RB
Citation: M. Mcgarvey et al., PARTICLE-SIZE ANALYSIS BY LASER DIFFRACTION IN ORGANIC PIGMENT TECHNOLOGY, Progress in organic coatings, 31(3), 1997, pp. 223-228
THE FOR-PROFIT CONVERSION OF EMPIRE-BLUE-CROSS QUESTION AND ANSWER SESSION I
Authors: LEIMAN JM SHERZER H STOCKER MA MCGARVEY M WRIGHT A GRAY BH
Citation: Jm. Leiman et al., THE FOR-PROFIT CONVERSION OF EMPIRE-BLUE-CROSS QUESTION AND ANSWER SESSION I, Bulletin of the New York Academy of Medicine, 74(2), 1997, pp. 213-219
A RANDOMIZED TRIAL OF TIRILAZAD MESYLATE IN PATIENTS WITH ACUTE STROKE (RANTTAS)
Authors: SCOTT P BARSAN W FREDERIKSEN S KRONICK S ZINK BJ DOMEIER RM MITCHINER JC JUDGE FP LEVY RJ ALEXIOU A REINCKE H SEGALL JD WALTERS B SWOR R GILROY J GOETTING M JACKSON R RICHARDSON D CISEK J RANDALL J SCHECTER S WILKINSON K WALTERS BL ADAMS R CARL E NICHOLS F HESS D BOOP B EARLEY C SMITH DR KAPLAN P JOHNSON C MORROW C FROHMAN E PORTER N FLANIGAN K MORGANSTERN L HOLLAND N STEIN A ALDRICH E OYLER G FAUGHT E MITCHELL V LIU H THOMAS F WENZEL D DAJANI BM PAN JL YAPUNDICH R FUTATSUGI Y GEERLINGS S MOSKOWITZ T NICHOLAS A BROCKINGTON J COLLINS A BAILEY JM TSENG A KOROSHETZ WJ CAN U FELIX A CUDKOWTICZ M BUONANNO F SCHWAMM L ELKIND M KISTLER JP FINKELSTEIN S CHA J MURPHY S BLUMENFELD H LOPEZBRESNAHAN M CAN U GOSLIN K CRAMER S SUWANWELA N HOMER D CARPENTER J WITYK R MICHEL N GRUFFERMAN S LITT B WEISS H GUYOT A PETERSON P TVARDEK L SCHMIDT J DESHPANDE A FREIJ W GANDHI B MINHAS F SHAH J ZAHKA C PENN A SHERMAN J LI YL ELLEKER MG STENERSON P BROOKE H ALJUMAH M ALAYAFY H POKROY R HOPPE B PASCUZZI R FARLOW M RIGHTMYER D BALES M CARESS J PETTIGREW C WAUGH C ROCKICH A FALLIS R TIKHTMAN A STARKMAN S SCHUBERT G DOBKIN B MARTIN N SAVER J HANSON S WEAVER A PORTH K MAGANA R DAVENPORT J TAYLOR F FREKING D HEROS DO SCHNEK E ALTER M RIBEIRO R LLOYD M SCHEINER S PUFF A BOYLE S GUPTA N WHITE K CARNEY S MOULTON M LACAPRA S HASSARD D RIZWAN S SHAH A NEWMARK A GUPTA A CONE D KHAN I COHEN B BOPARI R OCONNELL J HUSSIAN A PATIL K SHOJARI J RIBEIRO R BELL R GZECH D MAZER T GROTHUSEN J REYES P ARASTU J STRASSBURGER T THOMAS C WOLFE R FANG J SCAVINA M WOLFE W ZEIDWERG D CHAVIN J SHACHAR O SANDLER L MCGARREN D JAMIESON DG GONNELLA C BOSLEY TM POLLACK DA ANDREFSKY JC HARIHARAN S CHANG A LAMONTE MP CHAMPELLONE J HOOKER HC FELLUS J SOSA V RAAF S FRIEDMAN M BURCH G ATKINS D FOLEY C BIVINS D ELIAS W NOLAN D SISK M WILSON J LLOYD A STEPHENS G SURRUSCO R LOTHES C HUMPHRIES W PASTEMAK S DONATO M MANETTA E MITCHELL J BRIGGS A RORRER M OFFERMANN P GROVER W BOLTON B LYDEN P LEWIS S RAPP K BRODY M ROTHROCK J JACKSON C HUOTT P KUSHIDA C LISS J ZWEIFER R CAYLOR L PHAN D MAHDAVI Z TOM T NOACK H FORDE G CAMERON D GRIESDALE B MAKIN V BOZEK CB SHEPPARD G MASSEY S ZONTINE D CROWE N GUSTIN K CAPONE P FEASBY TE ROBERTSON C RORICK M WINKELMAN M LISKAY A SCHMIDLEY J COLE M ALJABERI M ANAGNOS A ANDERSON M BAMFORD C FREDERICKSON E GORDON J GROSSER S KORI A KUNTZ A MURAD M NASREDDINE W PETTEE A RIACHI N SCHECHT H STAHL J SORIANO J SUNSHINE J SUAREZ J VANDERSLUIS J ALLANHAM Y RAMAHI A SHUAIB A KADRIBASIC E STEWART B BEAUDRY M BOIVIN D LYONS G DOUGAL RL SIMSARIAN JP MCGARVEY M GRASS D SIGMUND L KURTZKE R EBERLY L LIPPS D FESENMEIER JT VIATER K ALONZO R COOPER W SCOTT J BUSTION P PAPPAS J FRAZER M HALEY EC ALVES W KASSELL NF JOHNSTON KC FORD G SOLENSKI N SHREVE DL WILKINSON SS CLEMENTS S CUCCIA E ELDER L KELLER M LACKEY R MIMMS K PROTZMAN P SPARROW L LIGHTFOOT A LIGHTFOOT AE BOCCHICCHIO BE HALLEY P POLIN A POLIN R HWANG LJ WOLF MC TRUSKOWSKI LL GALBRIETH C JOHNSON R JOHNSON S HILL C WILSON B BARTLEY A FORD G RUMFELT M WINGATE V SMITH M CHILDRESS T POWERS WJ WALKER M FLEISS JL FRANKEL M SIMON RP MARLER J ADAMS HP BROTT TG CHOI S KURTZKE JF TORNER JC PETERS GR ECKERT S BRYAN WJ BOLOGA ML LEGACE D BRENNAN KM
Citation: P. Scott et al., A RANDOMIZED TRIAL OF TIRILAZAD MESYLATE IN PATIENTS WITH ACUTE STROKE (RANTTAS), Stroke, 27(9), 1996, pp. 1453-1458
A DOMINANT-NEGATIVE MUTATION IN THE CONSERVED RNA HELICASE MOTIF SAT CAUSES SPLICING FACTOR PRP2 TO STALL IN SPLICEOSOMES
Authors: PLUMPTON M MCGARVEY M BEGGS JD
Citation: M. Plumpton et al., A DOMINANT-NEGATIVE MUTATION IN THE CONSERVED RNA HELICASE MOTIF SAT CAUSES SPLICING FACTOR PRP2 TO STALL IN SPLICEOSOMES, EMBO journal, 13(4), 1994, pp. 879-887
THE SPLICING FACTOR PRP2, A PUTATIVE RNA HELICASE, INTERACTS DIRECTLYWITH PRE-MESSENGER-RNA
Authors: TEIGELKAMP S MCGARVEY M PLUMPTON M BEGGS JD
Citation: S. Teigelkamp et al., THE SPLICING FACTOR PRP2, A PUTATIVE RNA HELICASE, INTERACTS DIRECTLYWITH PRE-MESSENGER-RNA, EMBO journal, 13(4), 1994, pp. 888-897
EFFECT OF TAMOXIFEN ON THE MULTIDRUG-RESISTANT PHENOTYPE IN HUMAN BREAST-CANCER CELLS - ISOBOLOGRAM, DRUG ACCUMULATION, AND M(R)-170,000 GLYCOPROTEIN (GP170) BINDING-STUDIES
Authors: LEONESSA F JACOBSON M BOYLE B LIPPMAN J MCGARVEY M CLARKE R
Citation: F. Leonessa et al., EFFECT OF TAMOXIFEN ON THE MULTIDRUG-RESISTANT PHENOTYPE IN HUMAN BREAST-CANCER CELLS - ISOBOLOGRAM, DRUG ACCUMULATION, AND M(R)-170,000 GLYCOPROTEIN (GP170) BINDING-STUDIES, Cancer research, 54(2), 1994, pp. 441-447
Risultati: 1-8 |